Membranous Nephropathy
📧 Sign up to get email alerts when something new happens for Membranous Nephropathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-03-25Clinical Trial Update: MOR202 for Refractory MN [Phase 2]
A Phase 2 clinical trial update on MOR202 for refractory membranous nephropathy, with the study status listed as completed.
-
CLINICAL_TRIALS research · 2025-03-25Clinical Trial Update: A Clinical Study of B007 in the Treatment of Primary Membranous Nephropathy. [Phase 2, Phase 3]
A Phase 2/3 clinical trial evaluating B007 for primary membranous nephropathy is currently recruiting, sponsored by Shanghai Jiaolian Drug R…
-
CLINICAL_TRIALS trial_result · 2025-02-13Clinical Trial Update: Phase II Study Assessing Safety and Efficacy of APL-2 in Glomerulopathies [Phase 2]
Phase II trial of APL-2 in glomerulopathies completed; results have been posted.
-
CLINICAL_TRIALS research · 2025-02-10Clinical Trial Update: A Phase I Clinical Study of Recombinant Humanized Anti-CD20(B-lymphocyte Antigen CD20) Monoclonal Antibody Subcutaneous Injection in the Treatment of Primary Membranous Nephropathy [Phase 1]
Phase I clinical trial evaluating a recombinant humanized anti-CD20 monoclonal antibody delivered by subcutaneous injection for primary memb…
-
CLINICAL_TRIALS trial_result · 2025-02-07Clinical Trial Update: Efficacy, Safety and PK/PD of MOR202 in Anti-PLA2R+ Membranous Nephropathy (aMN) (NewPLACE) [Phase 2]
Phase 2 results update reporting efficacy, safety and PK/PD of MOR202 in anti-PLA2R positive membranous nephropathy (NewPLACE).
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-01-07Clinical Trial Update: Raman Spectroscopy Diagnosis of Kidney Diseases
This update describes an ongoing clinical trial evaluating Raman spectroscopy as a diagnostic tool for kidney diseases, including IgA nephro…
-
CLINICAL_TRIALS trial_result · 2024-12-24Clinical Trial Update: Trial to Assess Safety and Efficacy of MOR202 in Anti-PLA2R + Membranous Nephropathy (aMN) [Phase 1, Phase 2]
This clinical trial update reports Phase 1/2 results for MOR202 in anti-PLA2R positive membranous nephropathy, with the study completed and …
-
CLINICAL_TRIALS research · 2024-11-26Clinical Trial Update: IM19 CAR-T Cell Therapy for IgA Nephropathy Patients and Membranous Nephropathy Patients [EARLY_Phase 1]
Early-phase (Phase 1) trial update for IM19 CAR-T cell therapy in IgA nephropathy and membranous nephropathy; the study is not yet recruitin…
-
CLINICAL_TRIALS trial_result · 2024-11-22Clinical Trial Update: A Study to Assess Effectiveness and Safety of Efgartigimod in Chinese Patients with Primary Membranous Nephropathy (ZL-1103-014) [Phase 2]
A Phase 2 trial evaluating efgartigimod in Chinese patients with primary membranous nephropathy was terminated.
-
CLINICAL_TRIALS trial_result · 2024-09-26Clinical Trial Update: The Efficacy and Safety of Treatment With Telitacicept in Primary Membranous Nephropathy [Phase 2]
This update covers a Phase 2 clinical trial evaluating the efficacy and safety of Telitacicept for primary membranous nephropathy, which is …
-
CLINICAL_TRIALS trial_result · 2024-06-13Clinical Trial Update: Clinical Trial of Anti-PLA2R-IgG Detection Kit (Time-resolved Fluorescence Immunoassay)
A completed clinical trial evaluating an Anti-PLA2R-IgG detection kit (time-resolved fluorescence immunoassay) for membranous nephropathy.
-
CLINICAL_TRIALS research · 2024-05-10Clinical Trial Update: Correlation and Clinical Utility of Urinary Biomarker in Membranous Glomerulonephritis
An ongoing clinical trial is evaluating the correlation between a urinary biomarker and disease activity, and its potential clinical utility…
-
CLINICAL_TRIALS trial_result · 2024-05-07Clinical Trial Update: Rituximab, Cyclophosphamide, and Corticosteroids in Primary Membranous Nephropathy [NA]
A clinical trial evaluating Rituximab, Cyclophosphamide, and Corticosteroids for PLA2R-induced membranous nephropathy is currently recruitin…
-
CLINICAL_TRIALS trial_result · 2024-05-02Clinical Trial Update: Study to Evaluate the Safety, Tolerability of BCX9930 in Participants With Either Complement 3 Glomerulopathy (C3G), Immunoglobulin A Nephropathy (IgAN), or Primary Membranous Nephropathy (PMN) [Phase 2]
Phase 2 study evaluating safety and tolerability of BCX9930 in complement-mediated kidney diseases was terminated; results have been posted.
-
CLINICAL_TRIALS research · 2024-04-25Clinical Trial Update: A Study of SNP-ACTH (1-39) Gel in Patients With Primary Membranous Nephropathy [Phase 3]
Cerium Pharmaceuticals reports a Phase 3 clinical trial of SNP-ACTH (1-39) Gel for primary membranous nephropathy, currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-04-02Clinical Trial Update: Clinical Study of Rituximab Combined With Corticosteroids or Rituximab Monotherapy in the Treatment of Primary Membranous Nephropathy [Phase 4]
Clinical trial update for a Phase 4 study evaluating rituximab with corticosteroids or rituximab monotherapy in primary membranous nephropat…
-
CLINICAL_TRIALS trial_result · 2023-09-05Clinical Trial Update: Evaluate the Efficacy and Safety of SHR1459 Tablets in Patients With Primary Membranous Nephropathy [Phase 2]
Phase 2 clinical trial update for SHR1459 tablets in patients with primary membranous nephropathy evaluating efficacy and safety.
-
CLINICAL_TRIALS trial_result · 2023-07-12Clinical Trial Update: Interferon Alfa Therapy Based on Th17 Profile in Membranous Nephropathy [Phase 2]
Phase 2 clinical trial evaluating interferon alfa therapy guided by Th17 profile for membranous nephropathy; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2022-08-15Clinical Trial Update: Adrenocorticotropic Hormone in Membranous Nephropathy [Phase 4]
A Phase 4 clinical trial evaluating adrenocorticotropic hormone in membranous nephropathy has completed with results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2020-01-18Clinical Trial Update: Sequential Therapy With Tacrolimus and Rituximab in Primary Membranous Nephropathy [Phase 3]
Phase 3 clinical trial evaluating sequential therapy with tacrolimus and rituximab for membranous nephropathy has completed.
-
CLINICAL_TRIALS trial_result · 2019-05-20Clinical Trial Update: Rituximab Versus Steroids and Cyclophosphamide in the Treatment of Idiopathic Membranous Nephropathy [Phase 3]
A phase 3 trial comparing rituximab to steroids and cyclophosphamide for idiopathic membranous nephropathy is being conducted, with status n…
-
CLINICAL_TRIALS trial_result · 2018-03-26Clinical Trial Update: Acthar for Treatment of Proteinuria in Membranous Nephropathy Patients [Phase 4]
Phase 4 trial update for Acthar in treating proteinuria due to membranous nephropathy has been completed with results posted.
-
CLINICAL_TRIALS trial_result · 2017-05-04Clinical Trial Update: A Dose Escalation Study of Long-acting ACTH Gel in Membranous Nephropathy [Phase 1, Phase 2]
This clinical trial update reports the completion of a Phase 1/2 dose-escalation study evaluating long-acting ACTH gel in membranous nephrop…
-
CLINICAL_TRIALS trial_result · 2015-08-03Clinical Trial Update: Tacrolimus for the Treatment of Systemic Lupus Erythematosus With Membranous Nephritis [Phase 4]
Phase 4 clinical trial update evaluating tacrolimus for treatment of systemic lupus erythematosus with membranous nephritis.
-
CLINICAL_TRIALS trial_result · 2015-06-01Clinical Trial Update: A Study of Belimumab in Idiopathic Membranous Glomerulonephropathy [Phase 2]
A Phase 2 study of belimumab in idiopathic membranous nephropathy has completed and posted results.